T. J. Barber, A. Hughes, W. W. Dinsmore and A. Phillips, “How Does HIV Impact on Non-AIDS Events in the Era of HAART?” International Journal of STD AIDS, Vol. 20, No. 1, 2009, pp. 1-3. doi:10.1258/ijsa.2008.008302
 M. A. Hacker, A. Kaida, R. S. Hogg and F. I. Bastos, “The First Ten Years: Achievements and Challenges of the Brazilian Program of Universal Access to HIV/AIDS Comprehensive Management and Care, 1996-2006,” Cadernos de Saúde Pública, Vol. 23, No. S3, 2007, pp. S345-S359.
 D. Ogoina et al., “Morbidity and Mortality Patterns of Hospitalised Adult HIV/AIDS Patients in the Era of Highly Active Antiretroviral Therapy: A 4-Year Retrospective Review from Zaria, Northern Nigeria,” AIDS Research and Treatment, Vol. 2012, No. 2012, 2012, Article ID: 940580.
 R. J. Zinn, C. Serrurier, S. Takuva, I. Sanne and C. N. Menezes, “HIV-Associated Lipodystrophy in South Africa: The Impact on the Patient and the Impact on the Plastic Surgeon,” Journal of Plastic, Reconstructive & Aesthetic Surgery, Vol. 66, No. 6, 2013, pp. 839-844. doi:10.1016/j.bjps.2013.02.032
 S. Emamzadeh-Fard, S. E. Fard, S. Seyed Alinaghi and K. Paydary, “Adherence to Anti-Retroviral Therapy and Its Determinants in HIV/AIDS Patients: A Review,” Infectious Disorders Drug Targets, Vol. 12, No. 5, 2012, pp. 346-356. doi:10.2174/187152612804142251
 S. Apanga, D. Punguyire and G. Adjei, “Estimating the Cost to Rural Ambulating HIV/AIDS Patients on Highly Active Antiretroviral Therapy (HAART) in Rural Ghana: A Pilot Study,” The Pan African Medical Journal, Vol. 12, No. 2012, 2012, p. 21.
 E. Naik et al., “Cost of Treatment: The Single Biggest Obstacle to HIV/AIDS Treatment Adherence in Lower-Middle Class Patients in Mumbai, India,” Indian Journal of Sexually Transmitted Diseases, Vol. 30, No. 1, 2009, pp. 23-27. doi:10.4103/0253-7184.55476
 J. C. Melchior et al., “Resting Energy Expenditure in Human Immunodeficiency Virus-Infected Patients: Comparison between Patients with and without Secondary Infections,” The American Journal of Clinical Nutrition, Vol. 57, No. 5, 1993, pp. 614-619.
 M. J. Batterham, “Investigating Heterogeneity in Studies of Resting Energy Expenditure in Persons with HIV/ AIDS: A Meta-Analysis,” The American Journal of Clinical Nutrition, Vol. 81, No. 3, 2005, pp. 702-713.
 W. W. Fawzi et al., “A Randomized Trial of Multivitamin Supplements and HIV Disease Progression and Mortality,” The New England Journal of Medicine, Vol. 351, No. 1, 2004, pp. 23-32. doi:10.1056/NEJMoa040541
 S. Jiamton et al., “A Randomized Trial of the Impact of Multiple Micronutrient Supplementation on Mortality among HIV-Infected Individuals Living in Bangkok,” AIDS, Vol. 17, No. 17, 2003, pp. 2461-2469. doi:10.1097/00002030-200311210-00008
 J. D. Kaiser et al., “Micronutrient Supplementation Increases CD4 Count in HIV-Infected Individuals on Highly Active Antiretroviral Therapy: A Prospective, Double-Blinded, Placebo-Controlled Trial,” Journal of Acquired Immune Deficiency Syndromes, Vol. 42, No. 5, 2006, pp. 523-528. doi:10.1097/01.qai.0000230529.25083.42
 K. Kawai et al., “A Randomized Trial to Determine the Optimal Dosage of Multivitamin Supplements to Reduce Adverse Pregnancy Outcomes among HIV-Infected Women in Tanzania,” The American Journal of Clinical Nutrition, Vol. 91, No. 2, 2010, pp. 391-397. doi:10.3945/ajcn.2009.28483
 R. D. Semba et al., “Micronutrient Supplements and Mortality of HIV-Infected Adults with Pulmonary TB: A Controlled Clinical Trial,” The International Journal of Tuberculosis and Lung Disease, Vol. 11, No. 8, 2007, pp. 854-859.
 J. E. Forrester and K. A. Sztam, “Micronutrients in HIV/ AIDS: Is There Evidence to Change the WHO 2003 Recommendations?” The American Journal of Clinical Nutrition, Vol. 94, No. 6, 2011, pp. 1683S-1689S. doi:10.3945/ajcn.111.011999
 N. Siegfried, J. H. Irlam, M. E. Visser and N. N. Rollins, “Micronutrient Supplementation in Pregnant Women with HIV Infection,” Cochrane Database of Systematic Reviews, Vol. 3, No. 2012, 2012, Article ID: CD009755.
 E. E. Lutge, A. Gray and N. Siegfried, “The Medical Use of Cannabis for Reducing Morbidity and Mortality in Patients with HIV/AIDS,” Cochrane Database of Systematic Reviews, Vol. 4, No. 2013, Article ID: CD005175.
 B. Holst and G. Williamson, “Nutrients and Phytochemicals: From Bioavailability to Bioefficacy beyond Antioxidants,” Current Opinion in Biotechnology, Vol. 19, No. 2, 2008, pp. 73-82. doi:10.1016/j.copbio.2008.03.003
 L. Z. Sun, N. L. Currier and S. C. Miller, “The American Coneflower: A Prophylactic Role Involving Nonspecific Immunity,” Journal of Alternative and Complementary Medicine, Vol. 5, No. 5, 1999, pp. 437-446. doi:10.1089/acm.1999.5.437
 B. B. Aggarwal and S. Shishodia, “Suppression of the Nuclear Factor-KappaB Activation Pathway by Spice-Derived Phytochemicals: Reasoning for Seasoning,” Annals of the New York Academy of Sciences, Vol. 1030, No. 2004, 2004, pp. 434-441.
 E. G. de Mejia and M. V. Ramirez-Mares, “Ardisia: Health-Promoting Properties and Toxicity of Phytochemicals and Extracts,” Toxicology Mechanisms and Methods, Vol. 21, No. 9, 2011, pp. 667-674. doi:10.3109/15376516.2011.601355
 D. O. Kennedy and E. L. Wightman, “Herbal Extracts and Phytochemicals: Plant Secondary Metabolites and the Enhancement of Human Brain Function,” Advances in Nutrition, Vol. 2, No. 1, 2011, pp. 32-50. doi:10.3945/an.110.000117
 M. H. Traka and R. F. Mithen, “Plant Science and Human Nutrition: Challenges in Assessing Health-Promoting Properties of Phytochemicals,” Plant Cell, Vol. 23, No. 7, 2011, pp. 2483-2497. doi:10.1105/tpc.111.087916
 G. Bagalkotkar, S. R. Sagineedu, M. S. Saad and J. Stanslas, “Phytochemicals from Phyllanthus Niruri Linn and Their Pharmacological Properties: A Review,” Journal of Pharmacy and Pharmacology, Vol. 58, No. 12, 2006, pp. 1559-1570. doi:10.1211/jpp.58.12.0001
 A. Imaz, V. Falco and E. Ribera, “Antiretroviral Salvage Therapy for Multiclass Drug-Resistant HIV-1-Infected Patients: From Clinical Trials to Daily Clinical Practice,” AIDS Reviews, Vol. 13, No. 3, 2011, pp. 180-193.
 J. F. Senise, A. Castelo and M. Martinez, “Current Treatment Strategies, Complications and Considerations for the Use of HIV Antiretroviral Therapy during Pregnancy,” AIDS Reviews, Vol. 13, No. 4, 2011, pp. 198-213.
 C. A. Shah, “Adherence to High Activity Antiretrovial Therapy (HAART) in Pediatric Patients Infected with HIV: Issues and Interventions,” Indian Journal of Pediatrics, Vol. 74, No. 1, 2007, pp. 55-60. doi:10.1007/s12098-007-0028-8
 R. Subbaraman, S. K. Chaguturu, K. H. Mayer, T. P. Flanigan and N. Kumarasamy, “Adverse Effects of Highly Active Antiretroviral Therapy in Developing Countries,” Clinical Infectious Diseases, Vol. 45, No. 8, 2007, pp. 1093-1101. doi:10.1086/521150